Lite Strategy Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jay File
Chief executive officer
US$912.7k
Total compensation
| CEO salary percentage | 59.35% |
| CEO tenure | 2.2yrs |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 17
Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)
Dec 30Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)
Nov 19We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely
May 18Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022
Mar 26Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts
Feb 12MEI Pharma: Another PI3K Delta Progressing To The FDA
Feb 01Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates
Dec 02We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate
Nov 04The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 11
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | US$913k | US$542k | -US$16m |
| Mar 31 2025 | n/a | n/a | -US$32m |
| Dec 31 2024 | n/a | n/a | -US$38m |
| Sep 30 2024 | n/a | n/a | -US$47m |
| Jun 30 2024 | US$615k | US$450k | US$18m |
| Mar 31 2024 | n/a | n/a | US$26m |
| Dec 31 2023 | n/a | n/a | US$20m |
| Sep 30 2023 | n/a | n/a | US$41m |
| Jun 30 2023 | US$321k | US$26k | -US$32m |
Compensation vs Market: Jay's total compensation ($USD912.67K) is above average for companies of similar size in the US market ($USD607.94K).
Compensation vs Earnings: Jay's compensation has increased whilst the company is unprofitable.
CEO
Jay File (55 yo)
Mr. Justin J. File, also known as Jay, serves as CFO & Corporate Secretary at Lite Strategy, Inc. (formerly known as MEI Pharma, Inc.) since August 01, 2023 and serves as its Acting Chief Executive Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Acting CEO | 2.2yrs | US$912.67k | no data | |
| Chief People Officer | 3.3yrs | no data | no data | |
| Strategic Advisor | 14.3yrs | US$755.98k | no data |
Experienced Management: LITS's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairperson | 7.7yrs | US$98.53k | 0.0053% $ 4.8k | |
| Independent Non-Executive Director | 12.3yrs | US$70.60k | 0% $ 0 | |
| Independent Non-Executive Director | 12.7yrs | US$63.10k | 0.0014% $ 1.3k | |
| Non-Executive Director | less than a year | no data | 0.82% $ 748.5k | |
| Independent Director | 1.9yrs | US$60.30k | 0.050% $ 45.8k | |
| Non-Executive Director | less than a year | no data | no data |
Experienced Board: LITS's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/06 23:10 |
| End of Day Share Price | 2025/10/06 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lite Strategy, Inc. is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephen V. Byrne | BofA Global Research |
| Jonathan Aschoff | Brean Capital |
| Gene Mack | Brean Capital |